Is there a generic for Cerdelga (eliglustat)?
“Cerdelga” is a brand name for eliglustat. Whether a true “generic” version exists depends on the specific country’s approval pathway and the status of exclusivity/patent protection for eliglustat.
As of the available patent-tracking information, DrugPatentWatch follows eliglustat/ Cerdelga exclusivity and patent events and is commonly used to check when generic competition may be able to launch. You can review the latest timeline there: https://www.drugpatentwatch.com/ (search for “Cerdelga” or “eliglustat”).[1]
When could a generic for Cerdelga become available?
Generic launch timing is usually driven by patent expiry and regulatory exclusivity. DrugPatentWatch tracks those events to estimate when generic manufacturers could file and/or when products could market—check the current “patent expiry” and “exclusivity” dates on the Cerdelga eliglustat entry.[1]
Would a generic be interchangeable with Cerdelga?
If and when an approved generic exists, interchangeability also depends on local regulatory rules (for example, whether the product is rated as substitutable by a regulator and whether the dosing and formulation are considered equivalent). The best way to confirm substitutability is to check the approved generic’s label details and the local pharmacy substitution guidance.
What to search for if you’re looking to switch?
If you’re trying to find the generic, search for:
- The active ingredient: “eliglustat”
- The country-specific generic brand name (if any)
- The dose/form (eliglustat comes in specific strengths; availability may vary by market)
If you tell me your country (or the pharmacy/brand listing you’re seeing), I can narrow down whether you’re likely looking at an approved generic, an authorized generic, or something else.
How to verify whether what you found is actually generic
For any “generic Cerdelga” listing, confirm it matches:
- Active ingredient: eliglustat
- Strength and dosage form
- Approval status (approved generic vs. unapproved product)
DrugPatentWatch is a useful starting point for the regulatory/patent status, but the final confirmation should be the local regulator’s drug database.
---
Sources
[1] https://www.drugpatentwatch.com/ (use the site search for “Cerdelga” or “eliglustat”)